Cargando…

PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer

Cancer-associated fibroblasts (CAFs) play significant roles in drug resistance through different ways. Antitumor therapies, including molecular targeted interventions, not only effect tumor cells but also modulate the phenotype and characteristics of CAFs, which can in turn blunt the therapeutic res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaoting, Fang, Tian, Xu, Sen, Jin, Ping, Zhou, Dongchen, Wang, Zhengzheng, Li, Huayi, Yang, Zongyuan, Chen, Gang, Zheng, Xu, Xia, Yu, Wei, Xiao, Zhang, Zeyu, Yang, Xin, Wang, Ya, Gao, Qinglei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190269/ https://www.ncbi.nlm.nih.gov/pubmed/34108603 http://dx.doi.org/10.1038/s41698-021-00189-w

Ejemplares similares

Targeting INHBA in Ovarian Cancer Cells Suppresses Cancer Xenograft Growth by Attenuating Stromal Fibroblast Activation
por: Li, Xiaoting, et al.
Publicado: (2019)

Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression
por: Yang, Zongyuan, et al.
Publicado: (2017)

MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis
por: Yang, Zongyuan, et al.
Publicado: (2016)

TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway
por: Wei, Xiao, et al.
Publicado: (2021)

Effectiveness and Safety of Niraparib as Neoadjuvant Therapy in Advanced Ovarian Cancer With Homologous Recombination Deficiency (NANT): Study Protocol for a Prospective, Multicenter, Exploratory, Phase 2, Single-Arm Study
por: Zhou, Dongchen, et al.
Publicado: (2022)

Suppression of GCH1 Sensitizes Ovarian Cancer and Breast Cancer to PARP Inhibitor
por: Wang, Siyuan, et al.
Publicado: (2023)

Increased CCL19 and CCL21 levels promote fibroblast ossification in ankylosing spondylitis hip ligament tissue
por: Qin, Yang, et al.
Publicado: (2014)

Dissecting the Autocrine and Paracrine Roles of the CCR2-CCL2 Axis in Tumor Survival and Angiogenesis
por: Izhak, Liat, et al.
Publicado: (2012)

Editorial: Small molecules and peptides in paracrine/autocrine regulation of ovarian folliculogenesis
por: Kim, So-Youn, et al.
Publicado: (2023)

Autocrine role of senescent cardiac fibroblasts-derived extracellular vesicles
por: FUJIOKA, Yusei, et al.
Publicado: (2023)

Correction: Dissecting the Autocrine and Paracrine Roles of the CCR2-CCL2 Axis in Tumor Survival and Angiogenesis
por: Izhak, Liat, et al.
Publicado: (2018)

Evaluation of the Efficacy and Safety of PARP Inhibitors in Advanced-Stage Epithelial Ovarian Cancer
por: Jiang, Yifan, et al.
Publicado: (2020)

The autocrine CXCR4/CXCL12 axis contributes to lung fibrosis through modulation of lung fibroblast activity
por: Li, Fei, et al.
Publicado: (2020)

PARP Inhibitors in Breast and Ovarian Cancer
por: Wang, Samuel S. Y., et al.
Publicado: (2023)

Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status
por: Wu, Yongsong, et al.
Publicado: (2023)

Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival
por: Pan, Yuan, et al.
Publicado: (2017)

PARP inhibitors in ovarian cancer
por: Cibula, David, et al.
Publicado: (2015)

Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
por: Kim, Hyoung, et al.
Publicado: (2020)

Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8
por: Jin, Rong, et al.
Publicado: (2023)

Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer
por: Dutta, Pranabananda, et al.
Publicado: (2020)

Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma
por: Wang, Chao, et al.
Publicado: (2020)

An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer
por: Xu, Jing, et al.
Publicado: (2022)

Blockade of Autocrine CCL5 Responses Inhibits Zika Virus Persistence and Spread in Human Brain Microvascular Endothelial Cells
por: Mladinich, Megan C., et al.
Publicado: (2021)

Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer
por: Gao, Qinglei, et al.
Publicado: (2019)

Glucocorticoid benefits the ventilatory function of severe/critical COVID-19 patients
por: Xiong, Xiaoming, et al.
Publicado: (2021)

TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells
por: Li, Wenqian, et al.
Publicado: (2017)

Correction: Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer
por: Gao, Qinglei, et al.
Publicado: (2019)

HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer
por: Ma, Hanlin, et al.
Publicado: (2022)

The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance
por: Asare-Werehene, Meshach, et al.
Publicado: (2019)

Delayed PARP-1 Inhibition Alleviates Post-stroke Inflammation in Male Versus Female Mice: Differences and Similarities
por: Chen, Jian, et al.
Publicado: (2020)

C/EBPβ promotes poly(ADP-ribose) polymerase inhibitor resistance by enhancing homologous recombination repair in high-grade serous ovarian cancer
por: Tan, Jiahong, et al.
Publicado: (2021)

CCL20 induces colorectal cancer neoplastic epithelial cell proliferation, migration, and further CCL20 production through autocrine HGF-c-Met and MSP-MSPR signaling pathways
por: Nandi, Bisweswar, et al.
Publicado: (2021)

Efficacy and Prognostic Factors for PARP Inhibitors in Patients With Ovarian Cancer
por: Huang, Xuan-zhang, et al.
Publicado: (2020)

YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progression
por: He, Chunbo, et al.
Publicado: (2015)

Combined PARP inhibitors and small molecular inhibitors in solid tumor treatment (Review)
por: Jin, Ning, et al.
Publicado: (2023)

Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism
por: Théou-Anton, N, et al.
Publicado: (2006)

Arsenic compound sensitizes homologous recombination proficient ovarian cancer to PARP inhibitors
por: Xu, Junfen, et al.
Publicado: (2021)

Reprogramming of Normal Fibroblasts into Cancer-Associated Fibroblasts by miRNAs-Mediated CCL2/VEGFA Signaling
por: Shen, Hua, et al.
Publicado: (2016)

PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms
por: Jiang, Xuan, et al.
Publicado: (2019)

Hormone autocrination by vascularized hydrogel delivery of ovary spheroids to rescue ovarian dysfunctions
por: Yoon, Hyo-Jin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_meqc17l0f477d6qtoelii4tu36